Trv Gp II, LLC
10% Owner

Trv Gp II, LLC insider trades: Revolution Medicines (RVMD) stock buys and sales

10% Owner, Revolution Medicines Last trade Jun 4, 2021 42 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2016
7
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Trv Gp II, LLC reports to the SEC

and 1 more company

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 4, 2021RVMD↓ Sell$16.4M
May 26, 2021RVMD↓ Sell$41.8M
May 25, 2021JNCE↓ Sell$4.4M
Mar 1, 2021JNCE↓ Sell$17.0M
Nov 19, 2020JNCE↓ Sell$105K
Nov 17, 2020JNCE↓ Sell$109K
Nov 6, 2017ALNA↑ Buy$3.0M
Sep 26, 2017MYOK↓ Sell$25.9M
Sep 11, 2017MYOK↓ Sell$9.1M
Mar 2, 2017GBT↓ Sell$52.2M
Feb 7, 2017BPMC↓ Sell$35.3M
Nov 14, 2016GBT↓ Sell$38.7M
May 16, 2016SAGE↓ Sell$26.6M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other RVMD insiders

Open-market trades in the last 12 months

About Trv Gp II, LLC's insider trades

Trv Gp II, LLC is a 10% owner of Revolution Medicines (RVMD). Since May 16, 2016, it has reported 1 open-market purchase worth $3.0M and 12 sales worth $267.6M on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include other transactions (23 filings), conversions (7 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RVMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.